JP2023154020A5 - - Google Patents

Download PDF

Info

Publication number
JP2023154020A5
JP2023154020A5 JP2023130574A JP2023130574A JP2023154020A5 JP 2023154020 A5 JP2023154020 A5 JP 2023154020A5 JP 2023130574 A JP2023130574 A JP 2023130574A JP 2023130574 A JP2023130574 A JP 2023130574A JP 2023154020 A5 JP2023154020 A5 JP 2023154020A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
acceptable carrier
excipient
dermatologically acceptable
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023130574A
Other languages
English (en)
Japanese (ja)
Other versions
JP7573078B2 (ja
JP2023154020A (ja
Filing date
Publication date
Priority claimed from JP2018515561A external-priority patent/JP2018528236A/ja
Application filed filed Critical
Publication of JP2023154020A publication Critical patent/JP2023154020A/ja
Publication of JP2023154020A5 publication Critical patent/JP2023154020A5/ja
Application granted granted Critical
Publication of JP7573078B2 publication Critical patent/JP7573078B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023130574A 2015-09-24 2023-08-10 真皮障害を治療または予防するための新規組成物および方法 Active JP7573078B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562232228P 2015-09-24 2015-09-24
US62/232,228 2015-09-24
JP2018515561A JP2018528236A (ja) 2015-09-24 2016-09-19 真皮障害を治療または予防するための新規組成物および方法
PCT/US2016/052442 WO2017053222A1 (en) 2015-09-24 2016-09-19 Novel compositions and methods for treating or preventing dermal disorders
JP2021169263A JP7332666B2 (ja) 2015-09-24 2021-10-15 真皮障害を治療または予防するための新規組成物および方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021169263A Division JP7332666B2 (ja) 2015-09-24 2021-10-15 真皮障害を治療または予防するための新規組成物および方法

Publications (3)

Publication Number Publication Date
JP2023154020A JP2023154020A (ja) 2023-10-18
JP2023154020A5 true JP2023154020A5 (cg-RX-API-DMAC7.html) 2024-04-08
JP7573078B2 JP7573078B2 (ja) 2024-10-24

Family

ID=58387119

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018515561A Withdrawn JP2018528236A (ja) 2015-09-24 2016-09-19 真皮障害を治療または予防するための新規組成物および方法
JP2021169263A Active JP7332666B2 (ja) 2015-09-24 2021-10-15 真皮障害を治療または予防するための新規組成物および方法
JP2023130574A Active JP7573078B2 (ja) 2015-09-24 2023-08-10 真皮障害を治療または予防するための新規組成物および方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2018515561A Withdrawn JP2018528236A (ja) 2015-09-24 2016-09-19 真皮障害を治療または予防するための新規組成物および方法
JP2021169263A Active JP7332666B2 (ja) 2015-09-24 2021-10-15 真皮障害を治療または予防するための新規組成物および方法

Country Status (9)

Country Link
US (4) US10695326B2 (cg-RX-API-DMAC7.html)
EP (2) EP3352755B1 (cg-RX-API-DMAC7.html)
JP (3) JP2018528236A (cg-RX-API-DMAC7.html)
KR (1) KR20180081501A (cg-RX-API-DMAC7.html)
CN (2) CN108348508A (cg-RX-API-DMAC7.html)
AU (1) AU2016325446B2 (cg-RX-API-DMAC7.html)
CA (1) CA3037469C (cg-RX-API-DMAC7.html)
ES (1) ES3060762T3 (cg-RX-API-DMAC7.html)
WO (1) WO2017053222A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10172789B2 (en) 2013-01-24 2019-01-08 Palvella Therapeutics Llc Compositions for transdermal delivery of mTOR inhibitors
WO2017053222A1 (en) * 2015-09-24 2017-03-30 Drexel University Novel compositions and methods for treating or preventing dermal disorders
US20190167649A1 (en) * 2016-08-10 2019-06-06 The Board Of Regents Of The University Of Texas System Topical rapamycin therapy
WO2018129364A1 (en) 2017-01-06 2018-07-12 Palvella Therapeutics Llc Anhydrous compositions of mtor inhibitors and methods of use
EP3817743A4 (en) 2018-07-02 2022-07-06 Palvella Therapeutics, Inc. ANHYDROUS COMPOSITIONS OF MTOR INHIBITORS AND METHODS OF USE
EP3863606A4 (en) * 2018-10-11 2022-07-20 Drexel University METHODS OF TREATMENT OR PREVENTION OF SKIN DISEASES
JP7516252B2 (ja) * 2018-11-02 2024-07-16 株式会社 資生堂 オルタナティブオートファジー誘導剤を含む紫外線起因性炎症抑制剤
KR102132921B1 (ko) * 2018-12-13 2020-07-13 영남대학교 산학협력단 조타로리무스를 유효성분으로 함유하는 세포노화 관련 질환 예방 또는 치료용 조성물
AU2020277132B1 (en) 2020-11-24 2021-11-04 Aft Pharmaceuticals Limited A Rapamycin Composition

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286730A (en) 1991-09-17 1994-02-15 American Home Products Corporation Method of treating immunoinflammatory disease
GB9723669D0 (en) 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
US6323219B1 (en) 1998-04-02 2001-11-27 Ortho-Mcneil Pharmaceutical, Inc. Methods for treating immunomediated inflammatory disorders
US20040180430A1 (en) 1999-09-07 2004-09-16 West Michael D. Methods of restoring telomere length and extending cell lifespan using nuclear transfer
US7026374B2 (en) 2002-06-25 2006-04-11 Aruna Nathan Injectable microdispersions for medical applications
EP1646635A1 (en) 2003-07-16 2006-04-19 Wyeth Cci-779 isomer c
US20050250805A1 (en) * 2004-05-06 2005-11-10 Glenmark Pharmaceuticals Limited Pharmaceutical ointment formulations
KR20070121746A (ko) 2005-03-14 2007-12-27 매크로켐 코포레이션 사람 피부를 통한 마크롤라이드 침투의 개선
AU2007230964B2 (en) 2006-03-23 2012-07-19 Santen Pharmaceutical Co., Ltd. Formulations and methods for vascular permeability-related diseases or conditions
MXPA06008797A (es) * 2006-08-03 2008-02-04 Fernando Ahumada Ayala Preparacion topica para el tratamiento de enfermedades inflamatorias de la piel que contiene sirolimus.
WO2008022256A2 (en) * 2006-08-16 2008-02-21 Blagosklonny Mikhail V Methods and compositions for preventing or treating age-related diseases
EP2155146A4 (en) 2007-05-15 2012-11-21 Puretech Ventures METHOD AND COMPOSITIONS FOR TREATING SKIN TREATMENTS
WO2009046436A1 (en) * 2007-10-04 2009-04-09 Memorial Sloan-Kettering Cancer Center Methods for inhibiting senescence of epithelial cells
WO2010056778A1 (en) * 2008-11-11 2010-05-20 Signum Biosciences, Inc. Isoprenyl compounds and methods thereof
AU2013204219B2 (en) * 2009-04-10 2015-05-07 Haiyan Qi Novel anti-aging agents and methods to identify them
WO2010118419A2 (en) * 2009-04-10 2010-10-14 Haiyan Qi Novel anti-aging agents and methods to identify them
US20110150856A1 (en) 2009-12-21 2011-06-23 Sarah Bacus Compositions and methods for treatment of vitiligo
WO2011079154A1 (en) * 2009-12-21 2011-06-30 Sarah Bacus Compositions and methods for treatment of vitiligo
JP5652795B2 (ja) * 2011-01-31 2015-01-14 国立大学法人大阪大学 皮膚疾患を処置するための外用薬およびその製造方法
WO2012142145A1 (en) 2011-04-12 2012-10-18 Dow Pharmaceutical Sciences Methods of treating skin conditions exhibiting telangiectasia
CN104080786A (zh) * 2011-11-08 2014-10-01 因特利凯有限责任公司 使用多种药剂的治疗方案
WO2014004692A1 (en) 2012-06-26 2014-01-03 Sarah Bacus Compositions and methods for treatment vitiligo
US9296733B2 (en) * 2012-11-12 2016-03-29 Novartis Ag Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
EA201690987A1 (ru) * 2013-11-13 2016-10-31 Новартис Аг Низкодозовые иммуностимулирующие ингибиторы mtor и их применения
US9980976B2 (en) * 2015-02-17 2018-05-29 Northwestern University Use of REDD1 inhibitors to dissociate therapeutic and adverse atrophogenic effects of glucocorticoid receptor agonists
WO2017053222A1 (en) 2015-09-24 2017-03-30 Drexel University Novel compositions and methods for treating or preventing dermal disorders

Similar Documents

Publication Publication Date Title
ES2587866T3 (es) Composición cosmética que comprende 4-(3-etoxi-4-hidroxifenil)-2-butanona
CA1339085C (fr) Compositions pharmaceutiques et cosmetiques a base de peroxyde de benzoyle et de sels d'ammonium quaternaires
JP2001508396A (ja) 皮膚調整製剤
JP2013515043A (ja) ジャスモン酸化合物を含む化粧品用組成物
JPH09501942A (ja) 石油ゼリークリーム剤
JP4242351B2 (ja) 油分吸収性局所組成物およびそれを用いる方法
US20200022898A1 (en) Film forming compositions and uses thereof
JP4359140B2 (ja) 異常な角質性物質を除去するための製剤
JP2001507686A (ja) 制汗剤又は消臭剤組成物
EP0966248B2 (fr) Compositions pour le traitement des matieres keratiniques contenant l'association d'un polymere zwitterionique et d'une silicone non-volatile et insoluble dans l'eau
JP2011510945A5 (cg-RX-API-DMAC7.html)
JP2920443B2 (ja) 角栓除去剤
JP2002322018A (ja) クリプトタンシノンを含むニキビ予防及び治療用化粧料組成物
CN110234310B (zh) 美容面膜和方法
US20060280703A1 (en) Antimycotic nail varnish
JP2002531474A (ja) デオドラント化粧品組成物
JP2002145753A (ja) 保湿用組成物及び該組成物を含有する化粧料
FR2976801A1 (fr) Composition cosmetique comprenant un polymere amphotere particulier, et un diester d'acide(s) gras et de polyethyleneglycol.
JP5734998B2 (ja) ベンジルオキシ−エチルアミン誘導体の防腐剤としての使用、防腐方法および組成物
FR2848827A1 (fr) Utilisation de dialkylsulfones dans des compositions cosmetiques de soin des ongles pour favoriser la pousse de l'ongle
FR3068886B1 (fr) Composition cosmetique aqueuse comprenant un derive d'acide pyridine-dicarboxylique et un hydroxystilbene
JP4001467B2 (ja) 育毛用の化粧料
JP3486930B2 (ja) 口腔用組成物
FR3030251A1 (fr) Composition comprenant un compose 4-(heterocycloalkyl)-benzene-1,3-diol et un solvant particulier
JPH09175965A (ja) 歯垢形成抑制剤及び口腔用組成物